Global EditionASIA 中文雙語Fran?ais
    China
    Home / China / Health

    Willingness to get COVID inoculations strong

    By WANG XIAOYU in Beijing and CHAI HUA in Shenzhen, Guangdong | China Daily | Updated: 2020-12-31 06:56
    Share
    Share - WeChat
    A resident is given a COVID-19 inoculation at a community health center on Wednesday in Shenzhen, Guangdong province. CHAI HUA/CHINA DAILY

    People qualified to get an emergency inoculation against COVID-19 in China have shown a strong willingness to take the shot, as evidence of homegrown vaccines' safety and efficacy continues to build, boosting the public's confidence.

    Leading vaccine developer Sinopharm said on Wednesday that an inactivated vaccine candidate created by a company unit in Beijing is 79.34 percent effective in protecting people against the virus and is generally safe, citing interim results from stage 3 clinical trials.

    The newly released efficacy rate has met requirements set by the World Health Organization and the National Medical Products Administration, the company said in a statement released on its website.

    The product can also induce a high level of neutralizing antibodies in 99.52 percent of recipients. This indicates that nearly all of them have generated immune responses against the virus, but not all responses are necessarily strong enough to fend it off.

    With these new developments, the company said it has already submitted an application for market approval to the top drug regulator, making it the first domestic vaccine developer to announce the crucial move.

    The experimental dose, developed by Sinopharm's Beijing Biological Products Institute, is one of three vaccines being rolled out for an emergency inoculation program targeting high-risk groups nationwide since July.

    The high-risk population includes those traveling to medium-or high-risk areas for work or study, as well as workers in customs, healthcare, the cold-chain industry and other public service sectors, according to the National Health Commission.

    Nearly 1 million people had received emergency doses as of late December, the commission said.

    As evidence on domestically developed vaccines accumulates and official market approval draws closer, the emergency campaign is proceeding smoothly across the country and has been met with high acceptance from the public, officials said.

    In Shenzhen, Guangdong province, five community clinics began vaccinating people against the virus this week. The two-dose vaccination is free of charge, but appointment slots are limited, according to the local government.

    On Tuesday, people waiting to get the shot were lined up at one of the centers in Nanshan district while more than a dozen medical workers were busy checking their information, setting up personal health files, administering the dose and confirming the date for the second shot.

    Among the recipients was Yan Weifan, a new graduate from a university in Hong Kong. He planned to travel to Hong Kong soon to get his diploma, which made him eligible for the emergency program.

    Yan said he waited for about an hour at the health center to get the shot and was instructed to remain there for 30 minutes for medical observation before leaving.

    "It felt like having a normal injection, with a little sore and swollen feeling," he said.

    Song Shuyi, director of the health center, said about 400 people were vaccinated on Monday, most of them students who plan to study abroad.

    High demand

    In Jinan, Shandong province, two hospitals were designated to administer emergency doses starting over the weekend, according to the city's health commission.

    Hospital workers stayed busy all day on Tuesday fielding calls about the vaccinations and booking slots, according to a medical worker at one Jinan hospital who declined to give his name.

    A similar eagerness to get vaccinated was reported in Wuhan, Hubei province, which began emergency inoculations on Dec 24 at 48 health clinics across the city.

    "I hope to get vaccinated as soon as possible so that I do not need to present nucleic acid test results each time I get a new job," said a 43-year-old housekeeper in Wuhan whose surname is Wang.

    In response to the high demand, local governments are stocking up on emergency doses and accelerating vaccinations for high-risk groups while abiding by regulations.

    Jing Jing, a senior official at Sichuan province's health commission, said during a conference on Dec 17 that the commission planned to complete administering the first doses to all key groups by Jan 15 and to finish the second injections by Feb 5.

    Health authorities said during a previous conference that annual manufacturing capacity for the vaccines in China will exceed 1 billion by the end of 2021.

    Liu Kun in Wuhan, Zhao Ruixue in Jinan and Zhang Zhihao in Beijing contributed to this story.

    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
     
    中文字字幕在线中文无码| 久久精品无码专区免费| 亚洲一本大道无码av天堂| 亚洲av中文无码乱人伦在线r▽ | 日本无码色情三级播放| 亚洲?V无码乱码国产精品| 久久亚洲精品无码AV红樱桃| 无码乱肉视频免费大全合集| 国色天香中文字幕在线视频| av无码免费一区二区三区| 日韩AV高清无码| 无码人妻精品一区二区蜜桃网站| 日本一区二区三区精品中文字幕 | 亚洲无码日韩精品第一页| 精品人妻大屁股白浆无码| 亚洲日韩国产AV无码无码精品| yellow中文字幕久久网| 亚洲欧美日韩中文字幕在线不卡| 一本大道无码日韩精品影视| 18无码粉嫩小泬无套在线观看 | 2019亚洲午夜无码天堂| 久久精品亚洲中文字幕无码麻豆| 成人午夜福利免费无码视频| 白嫩少妇激情无码| 久久男人中文字幕资源站| 中文无码成人免费视频在线观看| 天堂网www中文在线| 亚洲国产综合无码一区二区二三区| 久久久久久亚洲精品无码| 国产无遮挡无码视频免费软件| 午夜亚洲AV日韩AV无码大全 | 丰满白嫩人妻中出无码| 国产精品视频一区二区三区无码| 亚洲AV无码成人精品区蜜桃 | 精品少妇无码AV无码专区| 久久人妻少妇嫩草AV无码专区| 无码精品国产一区二区三区免费| 无码专区AAAAAA免费视频| 日韩精品无码久久久久久| 高清无码视频直接看| 无码8090精品久久一区|